FGFR4 and hepatocellular carcinoma: found that FGFR4 activates the SRC/STAT3 pathway, and FGFR4 forms an endosomal complex with SRC and STAT3, which enters the nucleus in HCC, representing a potential mechanism of action for the FGFR4 pathway complex.